• The company has cornered genetic modification of tobacco with over 200 patents, enabling it to produce both very low and very high nicotine level cigarettes.
• This IP provides several interesting and possibly large monetization opportunities.
• However, the company must first overcome the hurdle of ramping up production in order to eliminate losses and the need for additional financing.
• While there is progress on that front, it’s slower than hoped.

22nd Century’s Unique Cigarettes Create Growth Opportunities – 22nd Century Group, Inc. (NYSEMKT:XXII) | Seeking Alpha